BioSpace News Archive

Policy

MetP Pharma Receives US Patent for Drug Therapy of Demyelinating and Neuroinflammatory Diseases such as Multiple Sclerosis

Research shows modulation of the Hedgehog and androgen signaling pathways to discontinue the vicious circle leading to inflammation in the central nervous system and chronic demyelination

December 11, 2019
·
3 min read
PHARMASEAL Scoops its First Industry Award as Best Start-Up of the Year At Medilink East Midlands Business Awards 2019

PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces that is has won Start-Up of the Year in the 2019 Medilink East Midlands Business Awards.

December 11, 2019
·
3 min read
Policy

The Lower Drug Costs Now Act of 2019 – The Numbers Behind the Claims

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act (cited as the Lower Drug Costs Now Act of 2019), awaits a vote by the House in December.

December 11, 2019
·
4 min read
·
Gina Hagler
Promore Pharma has finalized recruitment of patients in HEAL LL-37 early

Promore Pharma AB announce that all patients in the company’s Phase IIb-study with LL-37 for treatment of venous leg ulcers have been recruited.

December 11, 2019
·
4 min read
OGT develops transformative constitutional NGS panel

Oxford Gene Technology, A Sysmex Group Company, has developed a breakthrough targeted NGS panel for constitutional cytogenetics research.

December 11, 2019
·
4 min read
Drug Development

BioSpace Global Roundup, Dec. 12

Companies from across the globe provide updates to their business and pipelines.

December 11, 2019
·
6 min read
·
Alex Keown
Business

Creoptix Appoints Line Stigen Raquet as Chief Executive Officer

Creoptix AG announced the appointment of Line Stigen Raquet as Chief Executive Officer with effect from beginning of January 2020.

December 11, 2019
·
2 min read
Business

BioArctic strengthens its management team with two strategic recruitments

BioArctic AB will be strengthening its management team in 2020 through two strategic recruitments.

December 11, 2019
·
2 min read
Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure

Owlstone Medical will receive funding to deploy Breath Biopsy® as part of EPHOR

December 11, 2019
·
6 min read
Drug Development

Sanofi Lines Up for Potential Approval of Cold Agglutinin Disease Treatment

Sanofi believes that sutimlimab, a novel investigational C1s inhibitor, has the potential to be the first approved treatment for cold agglutinin disease, a serious and chronic rare blood disorder.

December 11, 2019
·
2 min read
·
Alex Keown